— Most of what Professor Healy describes in the above presentation will sound pretty familiar to advocates of evidence-based medicine (EBM). And as he says, he’s not really against EBM, he’s against being blind to the limitations of poor trial data. I don’t think there is a single advocate of EBM who would disagree with […]
